Net Asset Categories

Unrestricted Net Assets

Education and General 10 Undesignated Operating
12 Undesignated T&E
14 Faculty Incentive Funds: These funds are also referred to as grant-in aid funds. Faculty incentive funds are provided to individual principal investigators to provide seed money or bridge funding to incentivize externally sponsored research funding or to bridge the gaps between awards. These funds are provided at the descretion of the Provost, Dean or Vice President for Research.. These funds are not permitted to carry deficits, however, surpluses are permitted to be carried over from fiscal year to fiscal year.
16 Return on Recovery: These funds capture facilities and administatrative (indirect) costs that were earned in a prior fiscal year which have subsequently been allocated to a dean, department or individual PI. These funds are not permitted to carry deficits, however surpluses may be carried over from fiscal year to fiscal year.
17 Patent
Physicians Practice Plan 18 Clinical Faculty Practice Plans
Externally Sponsored Activities 51 Deans and other department funds where original source was from contributions
53

Dean and other department funds where the source is income from board designated long-term investments or endowments where broad restrictions on use allow the funds to be expended within the current year

31 Other Federal Awards: Cost reimbursed or fixed price grants and contracts funded by other sources of the federal goverment not separately identified in the chart of accounts. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
33 National Science Foundation (NSF): Cost reimbursed or fixed priced grants and contracts funded exclusively by the NSF. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
35 Federal Clinical Trials: Federally funded clincial trials that are not cost reimbursed and are reimbursed based on capitation or patient enrollments are classified in this section of the chart of accounts. Unlike traditional cost reimbursable grants and contracts, these funds do carry a net asset balance. Deficits (overages) are not permitted to be carried forward from fiscal year to fiscal year. Departments are required to accrue revenues as earned based on invoicing or other supporting enrollment data.
36 Department of Health and Human Services (DHHS): Cost reimbursed or fixed priced grants and contracts funded exclusively by the DHHS that are not program/projects. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
39 Department of Health and Human Services (DHHS)-Program/Projects: Cost reimbursed or fixed priced grants and contracts funded exclusively by the DHHS that are considered program/projects. Program/Projects are those that are of a collaborative nature and involve multiple disciplines. Typically there are multiple funds associated with one grant for this projects. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
40 Federal Sub-contracts: Cost reimbursed or fixed priced grants and contracts funded by a federal agency but sub-contracted to Temple University by an another institution. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
42 State: Cost reimbursed or fixed priced grants and contracts where the grant or contract is negotiated directly with a state agency. These awards may have all or some portion that is federally funded. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
43 Local: Cost reimbursed or fixed price grants and contracts where the grant or contract is negotiated directly with a city or local governmental agency. These awards may have all or some portion that is federally funded. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
44 Voluntary Health Organizations: Cost reimbursed or fixed price grants and contracts where the grant or contract is negotiated directly with a voluntary health organization. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
45 State Funded Clinical Trials: State funded clincial trials that are not cost reimbursed and are reimbursed based on capitation or patient enrollments are classified in this section of the chart of accounts. Unlike traditional cost reimbursable grants and contracts, these funds do carry a net asset balance. Deficits (overages) are not permitted to be carried forward from fiscal year to fiscal year. Departments are required to accrue revenues as earned based on invoicing or other supporting enrollment data.
46 Industry: Cost reimbursed or fixed price grants and contracts where the grant or contract is negotiated directly with industry. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
47 Foundations: Cost reimbursed or fixed price grants and contracts where the grant or contract is negotiated directly with a foundation. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
49 Other Private Funding: Cost reimbursed or fixed price grants and contracts where the grant or contract is negotiated directly with private entity that is not a voluntary health organization, part of industry or a foundation. These funds are considered exchange transactions and as such they are unrestricted and typically have no net asset effect because revenues are recognized immediately when an expense is incurred. Deficits (overages) are not permitted to be carried forward from one fiscal year to another unless specifically exempted by Research Accounting Services.
55 Industry Sponsored Clinical Trials: Industry sponsored clincial trials that are not cost reimbursed and are reimbursed based on capitation or patient enrollments are classified in this section of the chart of accounts. Unlike traditional cost reimbursable grants and contracts, these funds do carry a net asset balance. Deficits (overages) are not permitted to be carried forward from fiscal year to fiscal year. Departments are required to accrue revenues as earned based on invoicing or other supporting enrollment data.
   
Unexpended Plant 80 Designated funds plant acquisitions and capital budgeting
83 Designated for renewal and replacement
Debt Service 85 Designated for retirement of indebtedness
Other Long-Term 65 Designated for student loans (including institutional share of federal programs)
87 Net fixed assets (University)
88 Net fixed assets (Commonwealth)
Quasi-Endowments 74 Board designated net assets from operating funds for long-term investments. Yield will post to 53 Center.
76 Quasi-endowments from operating budget

Temporarily Restricted Net Assets

Externally Sponsored Activities 21 Contributions other than capital where use is narrowly restricted or use spans longer than one year
23 Department funds where use is narrowly restricted or spans longer than one year and the source is from income generated from endowments
Contributory Sponsored Agreements 24 Voluntary Health Organizations: Contributions other than capital that are funded by a voluntary health organization, which is centered around an organized activity or project intended to produce specific research, instruction or public service outcome that may be indicated by some or all of the following: 1) a formal written proposal that indicates total project costs that may include facilities and adminstrative (indirect) cost recovery, 2) period written progress reports of a descriptive or technical nature and/or a detailed financial report, 3) requirements to comply with specific agency guidelines, whether programmatic and/or financial, 4) a specific time frame for performance.
26 Industry: Contributions other than capital that are funded by industy, which is centered around an organized activity or project intended to produce specific research, instruction or public service outcome that may be indicated by some or all of the following: 1) a formal written proposal that indicates total project costs that may include facilities and adminstrative (indirect) cost recovery, 2) period written progress reports of a descriptive or technical nature and/or a detailed financial report, 3) requirements to comply with specific agency guidelines, whether programmatic and/or financial, 4) a specific time frame for performance.
27 Foundations: Contributions other than capital that are funded by a foundation, which is centered around an organized activity or project intended to produce specific research, instruction or public service outcome that may be indicated by some or all of the following: 1) a formal written proposal that indicates total project costs that may include facilities and adminstrative (indirect) cost recovery, 2) period written progress reports of a descriptive or technical nature and/or a detailed financial report, 3) requirements to comply with specific agency guidelines, whether programmatic and/or financial, 4) a specific time frame for performance.
29 Other Private Funding: Contributions other than capital that are funded by a private funding source that is not a voluntary health organziation, industry or a foundation, which is centered around an organized activity or project intended to produce specific research, instruction or public service outcome that may be indicated by some or all of the following: 1) a formal written proposal that indicates total project costs that may include facilities and adminstrative (indirect) cost recovery, 2) period written progress reports of a descriptive or technical nature and/or a detailed financial report, 3) requirements to comply with specific agency guidelines, whether programmatic and/or financial, 4) a specific time frame for performance.
63 Student loans where use is narrowly restricted. (those not unrestricted or permanently restricted, i.e.: law foundation)
Unexpended Plant 81 contributions and endowment income where use is narrowly restricted or use spans longer than one year for capital purposes
Long Term Investment 71 Donor restricted endowments with time restriction based on donor's lifetime
77 Donor restricted endowments with time and narrowly restricted purpose

Permanently Restricted Net Assets

Externally Sponsored Activities 66 Student loans where use is narrowly restricted and or terms of contribution stipulate that the corpus cannot be invaded for any purpose such as bad debts
Endowment 72 True endowment where donor has stipulated that corpus be held in perpetuity (also included are trust funds held by others).
73 Donor-restricted endowments with time restrictions based on a donor's lifetime and the intention of eventually becoming a true endowment.

Agency Activity

90 Agency
61 Federal Perkins loans
62 Federal Health Profession loans
NOTE: Although set up as centers to facilitate accounting, any net balance will be reflected as liability.